6 Combat HIV/AIDS, malaria and other diseases

Where we are?

 Number of HIV cases in Kyrgyzstan as of Nov 2012.

The Kyrgyz Republic has been witnessing a sharp rise of newly registered HIV infections since 2001. This is largely determined by widespread practice of high-risk behavior and the low level of awareness among the general population. This can be also explained by location of the country on one of the three major drug trafficking transit routes from Afghanistan to Europe. Some drugs remain in the country, leading to growing drug consumption and HIV spread. The characteristics of the epidemic in the country bring high risk for rapid spread among populations at higher risk, from where it transfers to general population. Unemployment, labor migration, and social breakdown all continue to feed a situation where key populations at higher risk generate income through drug-trafficking and commercial sex.

As of November 1, 2012 the Republican AIDS Center registered 4532 people with HIV status. As of November 2012 new incidents made 645. There is a stable increase of HIV among women. However, this number does not reflect the real situation as many people living with HIV (PLHIV) keep their HIV-status in secret avoiding being the object of stigma and discrimination.

UNDP's work in Kyrgyzstan

  • National Programme on Prevention of HIV in Kyrgyzstan.

    Kyrgyzstan: Reducing Harm from HIV

    When he learned that he had acquired HIV from injecting drugs, 35-year-old Mirlan (not his real name) sought help from the Regional AIDS Prevention Centre inmore

Targets for MDG6
  1. Halt and begin to reverse the spread of HIV/AIDS
    • HIV prevalence among population aged 15-24 years
    • Condom use at last high-risk sex
    • Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
    • Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
  2. Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
    • Proportion of population with advanced HIV infection with access to antiretroviral drugs